Screener
International Flavors & Fragrances IFF Health & Biosciences — Additional charges, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by International Flavors & Fragrances in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The source filing: International Flavors & Fragrances’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:24 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000051253-26-000017
FAQ
- What is International Flavors & Fragrances's health & biosciences — additional charges, net?
- International Flavors & Fragrances (IFF) reported health & biosciences — additional charges, net of $2M in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — additional charges, net changed year-over-year?
- International Flavors & Fragrances's health & biosciences — additional charges, net decreased by 33.3% year-over-year, from $3M to $2M.
- What is the long-term trend for International Flavors & Fragrances's health & biosciences — additional charges, net?
- Over 3 years (2022 to 2025), International Flavors & Fragrances's health & biosciences — additional charges, net has grown at a 111.8% compound annual growth rate (CAGR), from $2M to $19M.
- What does health & biosciences — additional charges, net mean?
- Represents non-recurring or unusual expenses incurred by the Health & Biosciences segment that are excluded from core operating performance metrics. These charges typically include restructuring costs, integration expenses, or legal settlements that do not reflect ongoing business operations.
Ask your AI about International Flavors & Fragrances's health & biosciences — additional charges, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude